Xovoltib 30mg tablet | Apple pharmaceuticals


XOVOLTIB – 30MG

Description :

Xovoltib 30mg belongs to the class of medications called protein kinase inhibitors. It may also be used to treat other cancers as part of clinical trial. Xovoltib 30mg is a prescription drugs which is used under the supervision of medical practioners. Xovoltib 30mg is a targeted therapy drug used to treat non-small cell lung cancer (NSCLC).

Indication :

Xovoltib 30mg is used for the first-line therapy of patients with metastatic non-small cell lung cancer(NSCLC) whose cancer have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) changes mutations as detected by an FDA-approved test.

Dosage and administration :

For adult the dose for metastatic non-small cell lung cancer is the usual dose is 40mg taken once per day. For child dosage ages of 0-17 years is not been studied in children. The drug should not be used age under 18 years of age For renal impairment: usual dose is 30mg taken once per day Take Xovoltib on an empty stomach. Consume the drug 1 hour before or 2 hours after a meal Avoid cutting or crushing the tablet.

Precaution :

If patients have some serious condition then avoid the drug because the conditions will worse, the conditions like :

Embryo-fetal toxicity: Xovoltib 30mg will cause harm to the foetus when administrated to pregnant women
Keratitis: if patients confirm with suspected keratitis or ulcerative keratitis then stop or discontinue the drug
Hepatic toxicity
Interstitial lung disease (ILD)
Bullous and exfoliative skin disorders
diarrhae.


Side Effects :

• Loss of appetite
• Nausea
• Vomiting
• Diarrhoea
• Mouth sores
• Acne
• Itchiness
• Rash
• Dry skin
• Nail infection.

Serious side effects :

• Breathing trouble
• Cough and fever
• Yellowing the skins
• Brown coloured urine
• Bleeding or bruising
• Weakness
• Blurred vision
• Fast heartbeat.

Missed dose :

If patient fail to take the dose of Xovoltib 30mg, must consult with medical oncologist and follow the suggestions Do not self-medicate. The missed dose must be skipped and follow the regular dosing schedule Do not double the dose.

For More Information :

Call us : +91- 9987711567

Mail to : applepharmaceutical@gmail.com

Domain : http://anti-cancer-drugs.com/xovoltib-30mg.php

Comments

Post a Comment

Popular posts from this blog

velasof, velasof tablets ,uses - Myapplepharma

VELASOF TABLETS DESCRIPTION : Velasof   is the fixed dose combination of these two most widely used anti-viral agents. Sofosbuvir & Velpatasvir are directly acting anti-viral agents which are involved in the treatment of chronic hepatitis C viral infection. Sofosbuvir is usually combined with other anti-viral agent for exhibiting the prominent effects. DOSAGE BEFORE THE TREATMENT :  Care should be taken while using HCV medication in patients with HCV/HIV-1co infections, in this case HBV reactivation occurs.  Velasof   tablets are recommended for chronic condition of hepatitis C viral infection related to genotype 1, 2, 3, 4, 5 or 6. The dosing of  Velasof ; The usual recommended dose of  Velasof  is, one tablet should be administered orally as a single dose.  Velasof  tablet consist of 100mg of Velpatasvir & 400mg of Sofosbuvir.. WORKS AS :  This dynamic active moiety is get inserted into HCV RNA with the help of...
Read more

Today peoples are worried about NSLC – Xovoltib 30mg | Myapplepharma

  Xovoltib 30mg Description : Xovoltib 30mg is a prescription drugs which is used under the guidance of medical practioners. Xovoltib 30mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Indication : Xovoltib 30mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. Mechanism : Xovoltib 30mg dose can blocking the activating sites called tyrosine kinases of various proteins within the cell.By stopping these targets, it will target the cancer will shrink.These proteins are most likely to develop cancer growth when the tumor includes the EGFR gene mutation. Precautions : Diarrhae: Most normal condition for people administrating this medications to have diarrhea. Certain situation this diarrhea can be serious. Severe diarrhea can c...
Read more

Sprycel 20mg tablet | Apple pharmaceuticals

Image
Sprycel 20mg Description : Sprycel 20mg belongs to oral dual BCR/ABL and Src group of tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukaemia (CML). The main aim of Sprycel , are BCRABL, SRC, Ephrin’s and GFR. Sprycel 20mg is a prescription drug which used under the supervision of doctor. Indication : Sprycel 20mg   is indicated for the treatment of adult patients having chronic myeloid leukaemia. Sprycel 20mg is indicated for the treatment of adult patients having acute lymphoblastic leukaemia. DRUG INTERACTION :  Sprycel 20mg combination with CYP3A4 inducers will reduces Dasatinib plasma concentration. Sprycel 20mg combination with antacids will decrease Dasatinib plasma concentration. Sprycel 20mg combination with H2 antagonists/proton pump inhibitors will decrease Dasatinib plasma concentration. PRECAUTION :  Using of Sprycel will results in Tumor lysis syndrome; maintain sufficient hydration and correct ur...
Read more